Ranbaxy Launches Roliflo OD in India

Ranbaxy Laboratories Limited on Wednesday launched Roliflo OD (combination of Tamsulosin and Tolterodine) brand in the Indian market for the management of bladder outlet obstruction with concomitant overactive bladder, a chronic urological disorder.
NDTV Profit